July 16, 2013
Stephanie Chan will be leaving ITN to join a San Francisco-based private research company. First as a Clinical Operations Associate, and then as a Clinical Operations Manager, Stephanie has played a key role and made many contributions to the trials in the autoimmune therapeutic area, including ACCLAIM, AVATARS, ACCESS and CALIBRATE. We will be very sad to see her go. Stephanie’s last day will be Friday, July 19th.
Please join me in wishing her the best in her new position and future endeavors.
-Patti Tosta
More Information
